However, these are all speculative applications without any human trial evidence as of 2026
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
GSH ist in jeder Zelle des Krpers vorhanden
This makes stem cell therapy more likely to take [4]
Skin-enhancing peptides These therapies are often personalised following health checks and used in combinations or cycles with active medical guidance
Chrononutrition offers a practical framework to implement these interventions: by eating in harmony with our internal clock and choosing foods that support circadian and antioxidant functions, we may extend not just lifespan but health span, years of healthy, independent living